EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TRIM47 Regulates Energy Metabolism via Glycolytic Reprogramming to Drive Hepatocellular Carcinoma Progression and Represents an Efficient Therapeutic Target

Weijie Sun, Yihang Yuan, Qian Qiu, Kexuan Tan, Xutong Li, Haotian Li, Luyang Kang, Yuting Gu, Ziheng Zhang, Jiayu He, Jiali Li, Junjie Lin und 6 weitere

Advanced Science · 2026-03 · 13 (17)

DOI: 10.1002/advs.202416996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 03.02.2026. Verfasst von Weijie Sun und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Energy Metabolism, Glycolysis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Special Fund for Clinical Medical Research Transformation, Scientific Research Projects for Higher Education Institutions in Anhui Province, Anhui Provincial Health Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is an aggressive cancer with limited therapeutic targets and a poor prognosis. Aberrant energy metabolism plays a pivotal role in HCC progression by fulfilling the energy demands of rapidly proliferating tumor cells. In this study, tripartite motif‐containing protein 47 (TRIM47) was found to be significantly upregulated in patient‐derived HCC tissues, with clinical data revealing that higher TRIM47 expression correlates with poorer patient outcomes. Mechanistic investigations demonstrated that TRIM47 remodels energy metabolism by glycolytic reprogramming through its interaction with the K51 site of fructose‐1,6‐bisphosphatase (FBP1) through K48‐linked ubiquitination, thereby promoting HCC proliferation and tumor metastasis. Rescue experiments and bortezomib intervention experiments further confirmed that FBP1 is essential for mediating the oncogenic effects of TRIM47 in HCC progression. To explore its therapeutic potential, TRIM47 siRNA was developed and loaded into poly (lactic acid)‐DC‐Chol nanoparticles (siTRIM47@PD NPs), which significantly reduced tumor growth and metastasis in an orthotopic HCC animal model, highlighting the potential of TRIM47 as a therapeutic target. Together, these findings underscore the pivotal role of TRIM47 in HCC progression through FBP1‐mediated regulation of energy metabolism, and highlight siRNA‐based TRIM47 targeting as a promising approach to improve HCC treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularEnergy MetabolismGlycolysisCarrier ProteinsHumansAnimalsMetabolic ReprogrammingMiceDisease ProgressionCell Line, TumorCell ProliferationFructose-Bisphosphatase

Stichwörter der Autor:innen

TRIM47energy metabolism regulationglycolytic reprogramminghepatocellular carcinomasiRNA therapy

Substanzen

Carrier ProteinsFBP1 protein, humanFructose-Bisphosphatase

Autor:innen und Institutionen

  • Department of Infectious Disease, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
  • Anhui Province Key Laboratory of Infectious Diseases, Anhui Medical University, Hefei, China.
  • Department of General Surgery, Nanjing Drum Tower Hospital Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.

ORCID-Profile: Yang Zhang

Förderung

  • Anhui Provincial Special Fund for Clinical Medical Research Transformation
  • Scientific Research Projects for Higher Education Institutions in Anhui Province
  • Anhui Provincial Health Research Program
  • Central Universities Fundamental Research Funds In PUMC
  • Anhui Provincial Department of Science and Technology
  • Scientific Research Foundation of Education Department of Anhui Province of China
  • National Natural Science Foundation of China

Zitieren

APA

Sun, W., Yuan, Y., Qiu, Q., Tan, K., Li, X., Li, H., Kang, L., Gu, Y., Zhang, Z., He, J., Li, J., Lin, J., Xie, Z., Han, K., Li, J., Zhang, Y., Wu, T., & Gao, Y. (2026). TRIM47 Regulates Energy Metabolism via Glycolytic Reprogramming to Drive Hepatocellular Carcinoma Progression and Represents an Efficient Therapeutic Target. Advanced Science, 13(17). https://doi.org/10.1002/advs.202416996

Vancouver

Sun W, Yuan Y, Qiu Q, Tan K, Li X, Li H, et al. TRIM47 Regulates Energy Metabolism via Glycolytic Reprogramming to Drive Hepatocellular Carcinoma Progression and Represents an Efficient Therapeutic Target. Advanced Science. 2026;13(17). doi:10.1002/advs.202416996

BibTeX
@article{Sun2026,
  author = {Sun, Weijie and Yuan, Yihang and Qiu, Qian and Tan, Kexuan and Li, Xutong and Li, Haotian and Kang, Luyang and Gu, Yuting and Zhang, Ziheng and He, Jiayu and Li, Jiali and Lin, Junjie and Xie, Zihan and Han, Kexing and Li, Jiabin and Zhang, Yang and Wu, Ting and Gao, Yufeng},
  title = {TRIM47 Regulates Energy Metabolism via Glycolytic Reprogramming to Drive Hepatocellular Carcinoma Progression and Represents an Efficient Therapeutic Target},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {17},
  doi = {10.1002/advs.202416996}
}
Kostenlos starten →